Oxaliplatin added to fluoropyrimidine for adjuvant treatment of colorectal cancer is associated with long-term impairment of peripheral nerve sensory function and quality of life

Should the Benefit of Adjuvant Chemotherapy in Colon Cancer Be Re-Evaluated?

(2016) Lars A. Påhlman et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives

(2015) Marianne Ewertz et al.   ACTA ONCOLOGICA

Peripheral neuropathy in colorectal cancer survivors: The influence of oxaliplatin administration. Results from the population-based PROFILES registry

(2015) Antoinetta J. M. Beijers et al.   ACTA ONCOLOGICA

A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer

(2015) Bengt Gustavsson et al.   Clinical Colorectal Cancer

Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According toBRAFMutation and Mismatch Repair Status of the MOSAIC Study

(2015) Thierry André et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)

(2015) Deirdre R. Pachman et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature

(2014) Camilla Böckelman et al.   ACTA ONCOLOGICA

Incidence of Cold-Induced Peripheral Neuropathy and Dose Modification of Adjuvant Oxaliplatin-Based Chemotherapy for Patients with Colorectal Cancer

(2014) Rahim Altaf et al.   ONCOLOGY

A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration

(2014) A. J. M. Beijers et al.   SUPPORTIVE CARE IN CANCER

Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin

(2013) P. Alberti et al.   ANNALS OF ONCOLOGY

Oxaliplatin induced-neuropathy in digestive tumors

(2013) María Sereno et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Chemotherapy-Induced Neuropathy and Its Association With Quality of Life Among 2- to 11-Year Colorectal Cancer Survivors: Results From the Population-Based PROFILES Registry

(2013) Floortje Mols et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire

(2013) Ellen M. Lavoie Smith et al.   QUALITY OF LIFE RESEARCH

Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients

(2012) A. A. Argyriou et al.   ANNALS OF ONCOLOGY

Long-term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project trials C-07 and LTS-01

(2012) Kelley M. Kidwell et al.   CANCER

Idiopathic neuropathy: new paradigms, new promise

(2012) Mike A. Singer et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Reference values for the EORTC QLQ-C30 quality of life questionnaire in a random sample of the Swedish population

(2011) Maryam Derogar et al.   ACTA ONCOLOGICA

Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer

(2011) Daniel G. Haller et al.   JOURNAL OF CLINICAL ONCOLOGY

Capecitabine combined with oxaliplatin (CapOx) in clinical practice: how significant is peripheral neuropathy?

(2010) D. J. Storey et al.   ANNALS OF ONCOLOGY